no statement of use filed
on 17 Apr 2023
Last Applicant/ Owned by
65 Grove Street, Suite 303
Watertown
MA
02472
Serial Number
90273164 filed on 23rd Oct 2020
Registration Number
N/A
Correspondent Address
Roman Fayerberg
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
The mark consists of a Pegasus design. Platelets that are not bone marrow-derived, platelet variants, megakaryocytes, megakaryocytes variants, and products derived from platelets, megakaryocytes or their variants, and admixtures, namely, extracellular vesicles or exosomes, all the foregoing for medical or clinical use; platelet variants for medical or clinical use; pharmaceutical and drug deliverRead More
Platelets that are not bone marrow-derived, platelet variants, megakaryocytes, megakaryocytes variants, and products derived from platelets, megakaryocytes or their variants, and admixtures, namely, extracellular vesicles or exosomes, all the foregoing for medical or clinical use; platelet variants for medical or clinical use; pharmaceutical and drug delivery compositions comprising platelet variants for the treatment of tumors, immune-oncology, hematology, cardiovascular, inflammatory, immune and autoimmune diseases, conditions, or responses, critical care disorders, conditions and injuries, solid organ transplantation, wound healing, neurological disorders and orthopedics; Pharmaceutical compositions for drug delivery comprising non bone marrow-derived platelets, platelet variants for treatment of tumors, immune-oncology, hematology, cardiovascular, inflammatory, immune and autoimmune diseases, conditions, or responses, critical care disorders, conditions and injuries, solid organ transplantation, wound healing, neurological disorders and orthopedics; pharmaceutical compositions comprising platelet variants for transfusion in oncology, trauma and surgery; platelet variants for delivering proteins, antibodies, nucleic acids and other drugs to tumors, sites of vascular injury and inflammation, immune-oncology, hematology, cardiovascular, inflammatory, immune and autoimmune diseases, conditions, or responses, critical care disorders, conditions and injuries, solid organ transplantation, wound healing, neurological disorders and orthopedics; platelet variants for the treatment of tumors, immune-oncology, hematology, cardiovascular, inflammatory, immune and autoimmune diseases, conditions, or responses, critical care disorders, conditions and injuries, solid organ transplantation, wound healing, neurological disorders, and orthopedics; platelet variants as source for growth factors for medical or clinical use; compositions comprising viral vectors for medical or clinical use
No 90273164
No Service/Collective Mark
No 159224030200
No
No
No
No
No
No
No
No
04.05.03 -
Winged horses, including Pegasus
The mark consists of a Pegasus design.
| Status Date | Action Taken |
|---|---|
| 17th Apr 2023 | ABANDONMENT - NO USE STATEMENT FILED |
| 17th Apr 2023 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| 15th Sep 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 13th Sep 2022 | SOU EXTENSION 1 GRANTED |
| 13th Sep 2022 | SOU EXTENSION 1 FILED |
| 13th Sep 2022 | TEAS EXTENSION RECEIVED |
| 24th May 2022 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| 11th May 2022 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 06th Apr 2022 | TEAS POST PUBLICATION AMENDMENT RECEIVED |
| 15th Mar 2022 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
